EP
DCPH

Eversept Partners’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Eversept Partners’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-18,700
Closed -$635K – 128
2021
Q3 		$635K Buy
+18,700
New +$597K 0.04% 99

Other funds holding DCPH

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Eversept Partners's DCPH Position: Q2 2021 in Review

Eversept Partners sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 345,717 shares — an estimated $15.5M sold.

Eversept Partners first reported a position in DCPH in Q1 2018 and held it in 12 quarters. The position peaked at $25M in Q2 2020. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

  • Eversept Partners reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Eversept Partners sold 345,717 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $15.5M.
  • Eversept Partners first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2018 and held it in 12 quarters.
  • Eversept Partners's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $25M in Q2 2020.
  • 147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Eversept Partners's 13F filing for Q2 2021, filed 16 Aug 2021.